0
The Pediatric Forum |

Disabling Children With Disabilities

Ethan B. Ellis, MA
[+] Author Affiliations

Copyright 2007 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Pediatr Adolesc Med. 2007;161(4):419-420. doi:10.1001/archpedi.161.4.419-a
Text Size: A A A
Published online

The history of the medical maltreatment of and experimentation on people with developmental disabilities has been so common that it would be easy to dismiss the work of Gunther and Diekema,1 reported in their article “Attenuating Growth in Children With Profound Developmental Disability,” as just one more tragic example.

As a person with cerebral palsy who was not supposed to be able to walk, talk, or think but who has led his profession for 25 years and is married to a woman whose body is extensively scarred by failed experimental surgeries that were supposed to ameliorate her cerebral palsy, it would be even easier to dismiss their article with intense anger. That was my first reaction and the universal reaction of my colleagues in the disability movement.

The notion of further medically disabling a 6-year-old girl with a disability by stunting her growth for the convenience of her caregivers calls to mind a litany of other crimes committed against defenseless people with disabilities by good people in the name of bad ideas: ships of fools, institutionalization, eugenics, forced sterilization, experimentation with radiation and other deadly agents, and euthanasia. These ideas all had several things in common: they represented the best scientific and/or medical thinking of their times; they were endorsed by the leading organizations and individuals in the medical community; and people with disabilities had no say in their development or implementation. Most of them shared another fatal flaw: they attempted to impose medical solutions on what were essentially societal problems. That is certainly true in this case. It offers the wrong answer to a difficult problem, which requires a societal, not a medical, solution. The girl's family needs and should be entitled to the support needed to include her as a loving family member without intentionally deforming her body further.

Both the article by Gunther and Diekema1 and its editorial2 admit that the risks of the procedure are not fully known. Both recommend further research to determine those risks. That may be a logical conclusion to those trained in medicine. To people with disabilities, it is one more example of medical experimentation on people like us.

Stop it. We are not mice or rats or kitty cats. The final affront is to suggest that this matter is worthy of ethical debate.

AUTHOR INFORMATION

Correspondence: Mr Ellis, Alliance for Disabled in Action Inc, 629 Amboy Ave, Edison, NJ 08837 (eellis@adacil.org).

Financial Disclosure: None reported.

Gunther  DF, Diekema  DS. Attenuating growth in children with profound developmental disability: a new approach to an old dilemma. Arch Pediatr Adolesc Med 2006;1601013- 1017
PubMed
Brosco  JP, Feudtner  C. Growth attenuation: a diminutive solution to a daunting problem. Arch Pediatr Adolesc Med 2006;1601077- 1078
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Gunther  DF, Diekema  DS. Attenuating growth in children with profound developmental disability: a new approach to an old dilemma. Arch Pediatr Adolesc Med 2006;1601013- 1017
PubMed
Brosco  JP, Feudtner  C. Growth attenuation: a diminutive solution to a daunting problem. Arch Pediatr Adolesc Med 2006;1601077- 1078
PubMed

Correspondence

April 1, 2007
Daniel F. Gunther, MD, MA; Douglas S. Diekema, MD, MPH
Arch Pediatr Adolesc Med. 2007;161(4):419-420.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 7

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles